Journal
SENSORS
Volume 21, Issue 11, Pages -Publisher
MDPI
DOI: 10.3390/s21113763
Keywords
heart failure; remote monitoring; implantable cardioverter-defibrillator; cardiac resynchronization therapy; mortality; hospitalization
Ask authors/readers for more resources
Management of heart failure remains challenging despite advances in medical and pharmacological treatments. Strategies to reduce hospitalizations and readmission rates are urgently needed. Remote monitoring of high-risk patients, including those with cardiac implantable electronic devices, has shown promise in clinical practice for early identification of worsening heart failure.
The management of heart failure remains challenging despite evidence-based medical and pharmacological advances, especially in the ambulatory setting. There is an urgent need to develop strategies to reduce hospitalizations and readmission rates due to heart failure. Frequent monitoring of high-risk patients is imperative, and with the development of wireless and remote technology, frequent monitoring is now possible via remote monitoring. Nowadays, remote management of patients with cardiac implantable electronic devices is being increasingly adopted and integrated into clinical practice. Several clinical trials studied the impact of remote monitoring on clinical outcomes in patients with implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization defibrillators (CRT-Ds). This point of view will focus on the remote monitoring of ICDs and CRT-Ds in patients with heart failure and discusses whether remote monitoring can be used as a potential instrument for the early identification of patients at risk of worsening heart failure.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available